Full-Time

Account Executive

Screening

Posted on 5/3/2025

Guardant Health

Guardant Health

1,001-5,000 employees

Develops blood tests for cancer diagnostics

No salary listed

Mid, Senior

Phoenix, AZ, USA

Category
Field Sales
Sales & Account Management
Required Skills
Sales
Salesforce
Customer Service
Requirements
  • 4+ years of direct experience in a customer-facing sales role in the healthcare industry (diagnostics, medical device and/or pharmaceutical sales) with a solid history of 1) consistent closing abilities and 2) proven past performance that has met and exceeded expectations.
  • Comfortable communicating, presenting, selling to healthcare providers and office staff members.
  • Impeccable oral and verbal communication and presentation skills; superior listening and problem-solving skills.
  • Ability to engage in a consultative selling process that overcomes objections and indifferences while connecting client needs with GH capabilities.
  • Ability to maintain an outstanding level of market, customer, distribution and product knowledge necessary to accomplish sales objectives.
  • Excellent negotiation, problem-solving and customer service skills.
  • Ability to handle sensitive information and maintain a very high level of confidentiality.
  • Demonstrate ability to develop and utilize cross-functional relationships to facilitate the accomplishment of work goals and objectives.
  • Ability to work independently, communicate proactively, manage multiple projects and prioritize daily tasks while managing critical deadlines.
  • Ability to work effectively with minimal direction.
  • Strong administrative skills to manage business in complex environments. Must be proficient at in person, phone and virtual selling environments.
  • Must be very proficient with all Microsoft Office products & CRM systems (preferably Salesforce and Veeva).
  • Demonstrate Guardant Health values by acting with integrity, respect, trust and possess a very positive attitude and an understanding of the dynamics involved with organizational growth and change.
Responsibilities
  • Prospect and target healthcare providers for high utilization of SHIELD to screen patients for CRC and other cancers.
  • Meet or exceed sales goals, maximize promotional budgets, and execute the national sales strategy in accordance with Guardant Health standards.
  • Drive strategic business expansion/collaboration opportunities with primary care providers and their practices.
  • Develop and implement a business plan in line with brand strategy to support launch.
  • Identify and partner with national, regional and local laboratories that offer phlebotomy draw agreements. Initiate and secure lab service draw agreements, in-service and train specimen collection, workflow and.
  • Identify opportunities in the marketplace, share best practices, and proactively communicate strategies to cross-functional partners and members of the Commercial Team.
  • Continually analyze competitive landscape and environment within assigned accounts to determine trends and provide customer feedback to GHI leadership.
  • Structure detailed strategic plans for gaining and retaining new and existing clients.
  • Manage implementation of all promotional activities to support sales and marketing strategies, in accordance with high industry standards and company policies.
  • Work effectively with individuals across multiple departments throughout Guardant Health.
  • Collaborate and coordinate with sales team to ensure successful attainment of company goals and objectives.
  • Embrace, embody and represent the Guardant Health company culture at all times to external and internal constituents.
  • This is a field-based role – must have ability to travel daily within assigned territory and some travel outside of assigned area for regional or national meetings.
  • Uphold company mission and values through accountability, innovation, integrity, quality, and teamwork.
  • Support and comply with the company’s Quality Management System policies and procedures.
Desired Qualifications
  • Experience with sales/marketing of diagnostic products (blood-based testing and/or phlebotomy) directly to primary care healthcare providers and their practices.
  • Product launch planning and launch execution experience.
  • Familiarity with primary care practice landscape in territory.
  • High-touch customer service skills.

Guardant Health specializes in blood-based tests that provide essential information for cancer treatment and management. Their products are designed to assist patients at various stages of cancer, from early detection to managing advanced disease. The company develops and sells diagnostic tests that utilize blood samples to detect, monitor, and guide treatment decisions for cancer patients. Their main product, Guardant360, is FDA-approved and commonly used to help inform treatment choices for those with advanced cancer. Guardant Health is also working on expanding its offerings to include tests for early-stage cancer detection and monitoring for recurrence. By focusing on non-invasive and data-rich diagnostics, the company aims to enhance patient outcomes and lessen the overall impact of cancer.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Palo Alto, California

Founded

2012

Simplify Jobs

Simplify's Take

What believers are saying

  • Partnerships with Pfizer and Boehringer Ingelheim boost trust in liquid biopsy technology.
  • Collaboration with ConcertAI enhances cancer research through AI and real-world data integration.
  • Hereditary cancer testing launch opens new revenue streams and market opportunities.

What critics are saying

  • Increased competition from companies like Natera may impact market share.
  • Ongoing litigation with Natera poses potential legal and financial challenges.
  • Dependence on regulatory approval for new products could lead to delays.

What makes Guardant Health unique

  • Guardant Health specializes in blood-based tests for cancer treatment and management.
  • The company offers FDA-approved products like Guardant360 for advanced cancer treatment decisions.
  • Guardant Health is expanding into early-stage cancer detection and recurrence monitoring.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Performance Bonus

Growth & Insights and Company News

Headcount

6 month growth

↑ 0%

1 year growth

↑ 0%

2 year growth

↓ -1%
Health Technology Insights
May 20th, 2025
Guardant Health Launches Hereditary Cancer Testing for Risks

Guardant Health launches Hereditary Cancer testing for risks.

360Dx
Apr 24th, 2025
Guardant Health, Pfizer Partner to Use Liquid Biopsy to Aid Cancer Therapy Development

NEW YORK - Guardant Health said Thursday that it has entered a multiyear strategic collaboration with Pfizer, under which it will support the development and commercialization of cancer therapies using its Guardant Infinity liquid biopsy platform.

Asian Hospital & Healthcare Management
Jan 17th, 2025
Guardant Health and ConcertAI Partner to Launch Data-as-a-Service Platform Integrating Clinical and Tumour Profiling Data to Speed Up Cancer Therapy Research and Development

Guardant Health, a leading precision oncology company, has entered into a collaboration with ConcertAI, an oncology real-world evidence (RWD) data and AI technology company.

Hit Consultant
Jan 17th, 2025
Guardant Health And Concertai Partner To Unlock Cancer Insights With Multi-Modal Real-World Data

What You Should Know:– Guardant Health, a provider in precision oncology, and ConcertAI, a real-world evidence (RWE) and AI technology company in oncology, announced a strategic collaboration that will provide biopharmaceutical companies with access to a first-of-its-kind multi-modal real-world data (RWD) solution.– The partnership integrates comprehensive patient electronic medical record (EMR) data with genomic and epigenomic tumor profiling information, offering a deeper understanding of cancer biology and treatment response.Enhanced Cancer Research and DevelopmentCancer is a complex disease, and a patient’s response to treatment can be influenced by various factors, including specific genetic mutations, prior therapies, and the development of drug resistance. This new joint RWD solution provides critical clinical context to an extensive database of solid tumor cancer patients with multiple liquid biopsies. This allows biopharma researchers to:Better interpret disease biology: Gain a more comprehensive understanding of the underlying mechanisms driving cancer progression.Gain a more comprehensive understanding of the underlying mechanisms driving cancer progression. Identify drivers of tumor evolution: Pinpoint the specific genetic and epigenetic changes that contribute to tumor growth and spread.Pinpoint the specific genetic and epigenetic changes that contribute to tumor growth and spread. Understand resistance mechanisms: Uncover how tumors develop resistance to therapies, both intrinsically and over time.By leveraging this comprehensive dataset, combined with the analytics capabilities and AI SaaS solutions of both ConcertAI and Guardant Health, biopharmaceutical companies can gain a deeper understanding of cancer and develop more effective treatments.“Realizing the potential of precision medicine requires a comprehensive, multi-dimensional understanding of the tumor, the clinical environment and the patient’s response to therapy,” said Helmy Eltoukhy, Guardant Health co-CEO. “This partnership between Guardant and ConcertAI gives evidence and outcomes researchers access to extensive, robust data and AI-based modeling that can provide unprecedented insight into a patient’s cancer journey, including a tumor’s complex systemic interactions, to help them accelerate the development of much-needed cancer therapies

Guardant Health
Jan 2nd, 2025
Guardant Health to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

PALO ALTO, Calif.-(BUSINESS WIRE)- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will participate in the upcoming 43rd Annual J.P. Morgan Healthcare Conference in San Francisco.

INACTIVE